Literature DB >> 8662803

Aggregation of the FcepsilonRI on mast cells stimulates c-Jun amino-terminal kinase activity. A response inhibited by wortmannin.

T Ishizuka1, A Oshiba, N Sakata, N Terada, G L Johnson, E W Gelfand.   

Abstract

Aggregation of the high-affinity Fc receptors for immunoglobulin E (IgE) (FcepsilonRI) on the surface of mast cells initiates intracellular signal transduction pathways including the tyrosine phosphorylation of cellular proteins, phosphoinositide hydrolysis, an increase in intracellular calcium, and protein kinase C activation. These signals are believed to be involved in the exocytic release of inflammatory mediators such as vasoactive amines, cytokines, and lipid metabolites. However, the downstream consequences of these early activation events are not well defined. One exception is the activation of the extracellular signal-regulated kinases/mitogen-activated protein kinases. One member of the mitogen-activated protein kinase superfamily, designated c-Jun amino-terminal kinase (JNK), has been recently identified. JNK is activated following dual phosphorylation at a Thr-Pro-Tyr motif in response to diverse stimuli including tumor necrosis factor-alpha, heat shock, or ultraviolet irradiation. We found that JNK was strongly activated by antigen cross-linking in a mouse mast cell line passively sensitized with ovalbumin-specific IgE. Anti-mouse IgE antibody also activated JNK. MEK kinase 1 (MEKK1) which activates the JNK activator, JNK kinase (JNKK), was similarly activated by antigen stimulation. JNK but not p42(erk2) activation induced by antigen was significantly inhibited in the presence of wortmannin, a known inhibitor of phosphatidylinositol 3-kinase. These results indicate that in response to the aggregation of FcepsilonRI on mast cells, phosphatidylinositol 3-kinase activation is involved in the stimulation of the MEKK1, JNKK, JNK pathway.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8662803     DOI: 10.1074/jbc.271.22.12762

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Role of MEKK2-MEK5 in the regulation of TNF-alpha gene expression and MEKK2-MKK7 in the activation of c-Jun N-terminal kinase in mast cells.

Authors:  K Chayama; P J Papst; T P Garrington; J C Pratt; T Ishizuka; S Webb; S Ganiatsas; L I Zon; W Sun; G L Johnson; E W Gelfand
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

2.  Terreic acid, a quinone epoxide inhibitor of Bruton's tyrosine kinase.

Authors:  Y Kawakami; S E Hartman; E Kinoshita; H Suzuki; J Kitaura; L Yao; N Inagaki; A Franco; D Hata; M Maeda-Yamamoto; H Fukamachi; H Nagai; T Kawakami
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

3.  MEK kinases are regulated by EGF and selectively interact with Rac/Cdc42.

Authors:  G R Fanger; N L Johnson; G L Johnson
Journal:  EMBO J       Date:  1997-08-15       Impact factor: 11.598

4.  MEK kinase 1 gene disruption alters cell migration and c-Jun NH2-terminal kinase regulation but does not cause a measurable defect in NF-kappa B activation.

Authors:  T Yujiri; M Ware; C Widmann; R Oyer; D Russell; E Chan; Y Zaitsu; P Clarke; K Tyler; Y Oka; G R Fanger; P Henson; G L Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

5.  Mast cell tumor necrosis factor alpha production is regulated by MEK kinases.

Authors:  T Ishizuka; N Terada; P Gerwins; E Hamelmann; A Oshiba; G R Fanger; G L Johnson; E W Gelfand
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

6.  Inhibition of spleen tyrosine kinase prevents mast cell activation and airway hyperresponsiveness.

Authors:  Shigeki Matsubara; Guiming Li; Katsuyuki Takeda; Joan E Loader; Polly Pine; Esteban S Masuda; Nobuaki Miyahara; Satoko Miyahara; Joseph J Lucas; Azzeddine Dakhama; Erwin W Gelfand
Journal:  Am J Respir Crit Care Med       Date:  2005-09-28       Impact factor: 21.405

7.  Naturally occurring polyphenolic antioxidants modulate IgE-mediated mast cell activation.

Authors:  S Chen; J Gong; F Liu; U Mohammed
Journal:  Immunology       Date:  2000-08       Impact factor: 7.397

8.  Early growth response factor-1 induction by injury is triggered by release and paracrine activation by fibroblast growth factor-2.

Authors:  F S Santiago; H C Lowe; F L Day; C N Chesterman; L M Khachigian
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

9.  Inhibition of the antigen-induced activation of rodent mast cells by putative Janus kinase 3 inhibitors WHI-P131 and WHI-P154 in a Janus kinase 3-independent manner.

Authors:  Watchara Linwong; Noriyasu Hirasawa; Suzue Aoyama; Hirofumi Hamada; Takashi Saito; Kazuo Ohuchi
Journal:  Br J Pharmacol       Date:  2005-07       Impact factor: 8.739

10.  MEKK1 is essential for DT40 cell apoptosis in response to microtubule disruption.

Authors:  R Kwan; J Burnside; T Kurosaki; G Cheng
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.